Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups Clinical research trials and Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups. Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups clinical trial. Human subjects often get the best healthcare possible for their Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "O" Clinical Trials Conditions > Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups

Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups



Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups

For Condition: Candidiasis, Oral,HIV Infections
Status: Completed
Sponsor(s): National Institute of Dental and Craniofacial Research (NIDCR) , Columbia University
Synopsis: OBJECTIVES: I. Evaluate the development of oral manifestations of human immunodeficiency virus infection in relationship to the onset of immunologic alterations and systemic symptoms in different risk groups: gay/bisexual men, male intravenous drug users, and female intravenous drug users. II. Evaluate the immune and inflammatory response to periodontal and other microbial pathogens. III. Evaluate the bacterial species infecting the oral cavity in patients in these risk groups.
Details: PROTOCOL OUTLINE: Patients undergo a periodontal assessment every 6 months until medically unable to continue. The oral/dental exam includes saliva and gingival crevicular fluid analysis and, as indicated, oral photographs.
Eligibility:
Study Type:
  Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Human immunodeficiency virus infection (HIV) seropositive or seronegative At risk for HIV, i.e.: Gay/bisexual men Male intravenous drug users Female intravenous drug users No acquired immunodeficiency syndrome Currently enrolled in Columbia Presbyterian Medical Center protocol "The Natural History and Progression of HIV Infection"
Total Enrollment: 250

Location and Contact Information:

Overall Study Official:
IraLamster,  Study Chair,  Columbia University


Additional Information:
Study ID Numbers:
  199/11861;  CU-SDOS-5059
Study Start Date: September 1989
Record last reviewed: February 1997
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004781

Other Candidiasis, Oral Studies:
1. A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

2. A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

3. (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

4. Rapid HIV Tests for Women Late in Pregnancy and During Labor

5. Study of Anti-HIV Therapy Intensification

Related Studies:

Other Candidiasis, Oral Clinical Trials
Other Clinical Trials
Other Clinical Trials

Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups

Modify your Search

  Other Candidiasis, Oral Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103